Dear colleagues of Luye,

As we bid farewell to the fruitful and exciting year of 2015, we are about to step into the new year of 2016 which will be full of challenges but also great opportunities.

First of all, on behalf of the Board of Luye Group, I'd like to thank all of you for your hardwork, as well as the efforts and contributions that you have made in 2015. At the same time, I would like to express our deep gratitude to all the clients, partners, shareholders, and other sectors of the society for their tremendous support and trusts in Luye. Last but not least, I would like to express my deepest appreciation to all the families of our colleagues of Luye for their great support to the enterprise. Luye Group would not have obtained significant achievements without all the consolidated efforts.

The year of 2015 is a year with extraordinary success and accomplishments, a year with breakthroughs and stride leaps, as well as the start of our journey to expand into international pharmaceutical market.

After 21 years of innovative developments with persistence and steadiness, Luye Group has become an international group focusing on pharmaceutical and healthcare industry. In 2015, the medical and pharmaceutical sectors together made important breakthroughs in market globalization.

In 2015, Luye Pharma Group achieved significant milestones on new drugs research and development as well as international market registration. Several innovative microsphere formulations have made periodical achievements in the US FDA registration, among which Risperidone microsphere for injection (LY03004) would hopefully become the first new drug from China launching in the U.S market. In accordance with globalization requirement, pharmaceutical sector made continuous upgrades on the manufacturing and quality control systems which have passed overseas certifications. Many other segments are also under reforms so as to prepare for the penetration of innovative drug into the international healthcare markets.

In 2015, Luye Medical Group expanded into international healthcare industry, through a series of major overseas acquisitions in Singapore, Australia, and South Korea. The group aims to become the top private healthcare services provider globally, and the leading global comprehensive medical group in China.Luye Medical Group has also partnered with established and leading global medical brands and expertise and develops business and services networks in many major cities. We aim to convene business operations in the very near future. .

Luye is set to become an international major enterprise as we accelerate the rate of our global acquisitions, accompanied by explosive growth in the pool of international professionals and talents joining the Luye family. .

The year of 2016 would be a critical year to accelerate the realization of our international strategic objectives in 2020 as well as embracing new challenges from the journey of globalization. The group will increase the rate of implementing our globalization strategy, through organic growth and international mergers and acquisitions. Both the medical and pharmaceutical group will continue to uphold the principle of 'international standards towards Chinese markets', focusing on extensive exploration of the Chinese market, which is the biggest market with the greatest potential in the world, with higher-standard products, value adding services and adoption of advanced technologies, to elevate our globalization capabilities and branding. Luye Group is on its way to become the most respected leading international healthcare company. The group will strive to become a benchmark Chinese enterprise in the international pharmaceutical and healthcare industry.

My dearest Luye colleagues, let us continue to uphold the mission of 'serving the health of all human beings', convert 'Innovation makes Excellence' into our motivation to advance forward. Let us seize the opportunities, embrace the challenges, explore actively, break through bravely, and extend your arms to embrace the bright future of Luye's globalization.

In this New Year, on behalf of the board of Luye Group. I wish you, your families and friends a healthy, happy and blissful New Year.

Liu Dianbo
Chairman
Board of Luye Group


December 31, 2015

Luye Pharma Group Ltd. issued this content on 2015-12-31 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2015-12-31 15:23:21 UTC

Original Document: http://www.luye.cn/lvye_en/newsshow.php?id=451